Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency VKA anticoagulation reversal

被引：2
|
作者：
Dentali, Francesco [1 ]
Imberti, Davide [2 ]
Permunian, Eleonora Tamburini [1 ]
Croci, Ezio [3 ]
Ageno, Walter [1 ]
机构：
[1] Insubria Univ, Dept Clin Med, Varese, Italy
[2] Piacenza Hosp, Dept Internal Med, Haemostasis & Thrombosis Ctr, Piacenza, Italy
[3] Piacenza Hosp, Piacenza, Italy
来源：
THROMBOSIS AND HAEMOSTASIS | 2014年 / 112卷 / 03期
关键词：
INTERNATIONAL NORMALIZED RATIO; VITAMIN-K ANTAGONISTS; BLEEDING COMPLICATIONS;
D O I：
10.1160/TH13-10-0851
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：621 / 623
页数：3
相关论文
共 50 条
  • [41] 3-Factor versus 4-Factor Prothrombin Complex Concentrates for the Reversal of Vitamin K Antagonist-Associated Coagulopathy: A Systematic Review and Meta-analysis
    Puchstein, Dorothea
    Kork, Felix
    Schochl, Herbert
    Rayatdoost, Farahnaz
    Grottke, Oliver
    THROMBOSIS AND HAEMOSTASIS, 2023, 123 (01) : 40 - 53
  • [42] Is there a difference in efficacy, safety, and cost-effectiveness between 3-factor and 4-factor prothrombin complex concentrates among trauma patients on oral anticoagulants?
    Mangram, Alicia
    Oguntodu, Olakunle F.
    Dzandu, James K.
    Hollingworth, Alexzandra K.
    Hall, Scott
    Cung, Christina
    Rodriguez, Jason
    Yusupov, Igor
    Barletta, Jeffrey F.
    JOURNAL OF CRITICAL CARE, 2016, 33 : 252 - 256
  • [43] Systematic review: 3-factor versus 4-factor prothrombin complex concentrate for warfarin reversal: Does it matter?
    Voils, Stacy A.
    Baird, Brian
    THROMBOSIS RESEARCH, 2012, 130 (06) : 833 - 840
  • [44] Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab
    Honickel, Markus
    Treutler, Stefanie
    van Ryn, Joanne
    Tillmann, Sabine
    Rossaint, Rolf
    Grottke, Oliver
    THROMBOSIS AND HAEMOSTASIS, 2015, 113 (04) : 728 - 740
  • [45] Efficacy and safety of a prothrombin complex concentrate (Octaplex®) for rapid reversal of oral anticoagulation
    Lubetsky, A
    Hoffman, R
    Zimlichman, R
    Eldor, A
    Zvi, J
    Kostenko, V
    Brenner, B
    THROMBOSIS RESEARCH, 2004, 113 (06) : 371 - 378
  • [46] Emergency reversal of anticoagulation: The real use of prothrombin complex concentrates A prospective multicenter two year French study from 2006 to 2008
    Desmettre, Thibaut
    Dubart, Alain-Eric
    Capellier, Gilles
    Fanara, Benoit
    Puyraveau, Marc
    Kepka, Sabrina
    Coquart, Jeremy
    Sheppard, Frances
    Tazarourte, Karim
    THROMBOSIS RESEARCH, 2012, 130 (03) : E178 - E183
  • [47] Rapid Reversal of Warfarin-Associated Hemorrhage in the Emergency Department by Prothrombin Complex Concentrates
    Frumkin, Kenneth
    ANNALS OF EMERGENCY MEDICINE, 2013, 62 (06) : 616 - 626
  • [48] Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation
    Dickneite, Gerhard
    THROMBOSIS RESEARCH, 2007, 119 (05) : 643 - 651
  • [49] Fixed dosing of 4-factor prothrombin complex concentrate for reversal of anticoagulation
    Jung, B.
    Johnson, B.
    Kreuziger, L. Baumann
    HAEMOPHILIA, 2019, 25 : 34 - 34
  • [50] Kcentra: A 4-Factor Prothrombin Complex Concentrate for Reversal of Warfarin Anticoagulation
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1420): : 53 - 54
12345